Form 4: Moderna President Stephen Hoge Reports Stock Transactions

Moderna's President, Stephen Hoge, executed stock transactions involving the vesting of restricted stock units and sales to cover tax obligations.

Summary

• Stephen Hoge, President of Moderna, reported transactions involving the company's common stock.
• On November 27, 2024, 610 restricted stock units (RSUs) vested and converted into common stock.
• On November 29, 2024, 291 shares were sold at a price of $42.7891 per share to cover tax withholding obligations related to the vesting of the RSUs.
• Following these transactions, Mr. Hoge directly owns 1,443,567 shares of Moderna common stock.
• He also indirectly owns 4,116 shares through Valhalla, LLC and 151,933 shares through a trust for the benefit of his spouse and children.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing detailing stock transactions by an executive, which is neither positive nor negative for the company's outlook.

Industry Context

This is a routine filing related to insider transactions, which is common for executives of publicly traded companies. These transactions are often related to vesting schedules and tax obligations.

Comparison to Industry Standards

• The transactions are typical for executives at publicly traded companies like Moderna, similar to filings from executives at companies such as Pfizer, BioNTech, and Johnson & Johnson.
• The 'sell to cover' mechanism for tax obligations is a standard practice in equity compensation plans across the industry.

Stakeholder Impact

• The transactions have a minimal impact on shareholders as they are routine and related to executive compensation.

Key Dates

Keywords

Moderna, MRNA, Stephen Hoge, stock transaction, restricted stock units, RSU, insider trading, Form 4, SEC